Science

植物&动物 | 生态&环境 | 大脑&行为 | 健康 | 技术 | 科学&政策 | 进化 | 古生物学 | 细胞 | 分子 | 基因&蛋白 | 遗传&发育 | 生物化学 | 生物物理 | 免疫 | 人物&事件 | 微生物学 |
当前位置: Science » Science封面 » Science封面:血管如何应对损伤

Science封面:血管如何应对损伤

摘要 : 本周Science封面研究的一篇文章,描述了如何在老鼠受伤血管中增加转录因子GATA-6的活动防止血管平滑肌细胞过度增殖同时形成一种称为“新内膜”疤痕组织,使血管腔变窄。

 2015_05_8_376_pc12

本周Science封面研究的一篇文章,描述了如何在老鼠受伤血管中增加转录因子GATA-6的活动防止血管平滑肌细胞过度增殖同时形成一种称为“新内膜”疤痕组织,使血管腔变窄。图像显示了在内皮细胞层衬腔内部和内部弹性板(深棕色的波浪线)之间产生了“新内膜”去以应对损伤。(图片:余金和余玉/耶鲁大学医学院)

原文链接:

Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition

原文摘要:

Vascular smooth muscle cells (VSMCs) undergo transcriptionally regulated reversible differentiation in growing and injured blood vessels. This dedifferentiation also contributes to VSMC hyperplasia after vascular injury, including that caused by angioplasty and stenting. Stents provide mechanical support and can contain and release rapamycin, an inhibitor of the mechanistic target of rapamycin complex 1 (mTORC1). Rapamycin suppresses VSMC hyperplasia and promotes VSMC differentiation. We report that rapamycin-induced differentiation of VSMCs required the transcription factor GATA-6. Inhibition of mTORC1 stabilized GATA-6 and promoted the nuclear accumulation of GATA-6, its binding to DNA, its transactivation of promoters encoding contractile proteins, and its inhibition of proliferation. These effects were mediated by phosphorylation of GATA-6 at Ser290, potentially by Akt2, a kinase that is activated in VSMCs when mTORC1 is inhibited. Rapamycin induced phosphorylation of GATA-6 in wild-type mice, but not in Akt2−/− mice. Intimal hyperplasia after arterial injury was greater in Akt2−/−mice than in wild-type mice, and the exacerbated response in Akt2−/− mice was rescued to a greater extent by local overexpression of the wild-type or phosphomimetic (S290D) mutant GATA-6 than by that of the phosphorylation-deficient (S290A) mutant. Our data indicated that GATA-6 and Akt2 are involved in the mTORC1-mediated regulation of VSMC proliferation and differentiation. Identifying the downstream transcriptional targets of mTORC1 may provide cell type–specific drug targets to combat cardiovascular diseases associated with excessive proliferation of VSMCs.

来源: Science 浏览次数:0

我们欢迎生命科学领域研究成果、行业信息、翻译原创、实验技术、采访约稿。-->投稿

RSS订阅 | 生物帮 | 粤ICP备11050685号-3 ©2011-2014 生物帮 Science  All rights reserved.